On June 4, 2025, AVITA Medical held its Annual Meeting where stockholders approved an increase of 2,500,000 shares under the Amended and Restated Omnibus Incentive Plan, totaling 6,750,000 shares. The meeting also saw the election of seven directors and the approval of various compensation proposals, including options for CEO James Corbett to acquire 520,000 shares.